+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Food and Drug Administration--Prescription drug products; patient package inserts requirements. Final rule



Food and Drug Administration--Prescription drug products; patient package inserts requirements. Final rule



Federal Register 45(179 Pt 2): 60754-60784



The Food and Drug Administration [FDA] adopts final regulations establishing requirements and procedures for the preparation and distribution of patient package inserts for prescription drugs for human use. The package inserts will inform the patient about the drug product. This action is intended to promote the safe and effective use of prescription drug products by patients and to ensure that patients have the opportunity to be informed of the benefits and risks involved in the use of prescription drug products. The agency intends to apply the regulations to 10 drugs or drug classes during an initial implementation program. Further evaluation of the costs and benefits of the program will guide the agency in deciding whether to extend, revise, or defer these requirements.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 046111374

Download citation: RISBibTeXText

PMID: 10248285


Related references

Prescription drug products that require patient package inserts; ampicillin and phenytoin--Food and Drug Administration. Final rule. Federal Register 46(1): 28-28, 1980

Prescription drug products; patient package insert requirements--Food and Drug Administration. Final rule. Federal Register 46(1): 28-30, 1980

Prescription drug products; revocation of patient package insert requirements--Food and Drug Administration. Final rule. Federal Register 47(173): 39147-39155, 1982

Prescription drugs; revocation of final guideline patient package inserts and withdrawal of draft guideline patient package inserts--Food and Drug Administration. Notice. Federal Register 47(173): 39249-39250, 1982

Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; policies, requirements, and administrative procedures. Food and Drug Administration, HHS. Final rule. Federal Register 64(232): 67720-67763, 2000

Progestational drug products for human use; requirements for labeling directed to the patient. Food and Drug Administration, HHS. Final rule. Federal Register 64(220): 62110-2, 2000

The usa food and drug administration retreats from patient package inserts for prescription drugs. Food Drug Cosmetic Law Journal 40(2): 172-187, 1985

Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; amendment of final monograph for OTC antitussive drug products. Food and Drug Administration, HHS. Final rule. Federal Register 65(148): 46864-8, 2000

Distribution of certain drug products by registered blood establishments and comprehensive hemophilia diagnostic treatment centers that qualify as health care entities; Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; policies, requirements and administrative procedures. Final rule. Federal Register 73(197): 59496-59501, 2008

Topical antifungal drug products for over-the-counter human use; amendment of final monograph. Food and Drug Administration, HHS. Final rule. Federal Register 65(168): 52302-5, 2000

Sunscreen drug products for over-the-counter human use; final monograph. Food and Drug Administration, HHS. Final rule. Federal Register 64(98): 27666-27693, 1999

Content and format for labeling for human prescription drugs; amendment of effective date for certain biological products--Food and Drug Administration. Final rule. Federal Register 46(15 Pt 1): 7271-7273, 1981

Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; policies, requirements, and administrative procedures; delay of effective date; reopening of administrative record. Food and Drug Administration, HHS. Final rule; delay of effective date; reopening of administrative record. Federal Register 65(86): 25639-25641, 2000

Applications for Food and Drug Administration application approval to market a new drug; revision of postmarketing reporting requirements. Final rule. Federal Register 72(201): 58993-59000, 2007

Laxative drug products for over-the-counter human use. Food and Drug Administration, HHS. Final rule. Federal Register 64(19): 4535-4540, 1999